Who owns Clover stock?

Clover Health Investments (NASDAQ: CLOV) boasts a diverse ownership structure, with a significant portion of its shares held by various types of investors. A total of 14.72% of the company's shares are owned by institutional shareholders, indicating the trust and confidence that financial institutions have in Clover Health's potential.

In addition to institutional investors, Clover Health also has a substantial insider ownership, with 27.14% of its shares held by company insiders. This high level of insider ownership suggests a strong alignment of interests between management and shareholders, fostering a sense of accountability and commitment to the company's long-term success.

Retail investors, who have become increasingly active in the stock market, hold the largest share of Clover Health Investments, accounting for 58.14% of the total ownership. This demonstrates the widespread appeal and popularity of Clover Health among individual investors, who are attracted by the company's growth prospects and potential returns.

Among the individual shareholders, Chamath Palihapitiya stands out as the largest shareholder of Clover Health Investments. With 60.65 million shares under his ownership, he represents a significant 12.19% of the company's total shares. Palihapitiya's significant investment in Clover Health underscores his belief in the company's vision and its ability to revolutionize the healthcare industry.

BTCC, a leading cryptocurrency exchange, offers a wide range of services that cater to the diverse needs of its clients. These services include spot trading, which allows users to buy and sell cryptocurrencies at the current market price, as well as futures trading, providing traders with the opportunity to speculate on the future price movements of various digital assets.